# Ladan Zand

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ladan-zand/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,383 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 38 |
| i10-index | 71 |
| Last Known Institution | Mayo Clinic |
| OpenAlex ID | https://openalex.org/A5022727703 |
| ORCID iD | 0000-0001-5812-9809 |
| Works | 164 |

## Researcher papers

- [C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up](https://scholariq.org/papers/c3-glomerulonephritis-clinicopathological-findings-complement-abnormalities/)
- [Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement](https://scholariq.org/papers/atypical-postinfectious-glomerulonephritis-is-associated-with-abnormalities-in/)
- [Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies](https://scholariq.org/papers/noninvasive-diagnosis-of-primary-membranous-nephropathy-using-phospholipase-a2/)
- [Clinical Findings, Pathology, and Outcomes of C3GN after Kidney Transplantation](https://scholariq.org/papers/clinical-findings-pathology-and-outcomes-of-c3gn-after-kidney-transplantation/)
- [Membranoproliferative Glomerulonephritis Secondary to Monoclonal Gammopathy](https://scholariq.org/papers/membranoproliferative-glomerulonephritis-secondary-to-monoclonal-gammopathy/)
- [COVID-19 Vaccination and Glomerulonephritis](https://scholariq.org/papers/covid-19-vaccination-and-glomerulonephritis/)
- [C3 Glomerulonephritis Associated With Monoclonal Gammopathy: A Case Series](https://scholariq.org/papers/c3-glomerulonephritis-associated-with-monoclonal-gammopathy-a-case-series/)
- [Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification](https://scholariq.org/papers/mayo-clinic-consensus-report-on-membranous-nephropathy-proposal-for-a-novel/)
- [Successful Treatment of Patients With Refractory PLA2R-Associated Membranous Nephropathy With Obinutuzumab: A Report of 3 Cases](https://scholariq.org/papers/successful-treatment-of-patients-with-refractory-pla2r-associated-membranous/)
- [Pregnancy outcomes in autosomal dominant polycystic kidney disease: a case-control study](https://scholariq.org/papers/pregnancy-outcomes-in-autosomal-dominant-polycystic-kidney-disease-a-case/)
- [Incidence, Prevalence, and Mortality of Lupus Nephritis: A <scp>Population‐Based</scp> Study Over Four Decades Using the Lupus Midwest Network](https://scholariq.org/papers/incidence-prevalence-and-mortality-of-lupus-nephritis-a-scp-population-based-scp/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Researcher university

- [Mayo Clinic](https://scholariq.org/institutions/mayo-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.